Surgical Devices
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
330
NCT03226626
Tumescent Anesthesia Antibiotic Delivery (TAAD)
Phase: Phase 2/3
Role: Lead Sponsor
Start: Dec 1, 2021
Completion: Jul 31, 2022
Loading map...